A detailed history of Eqis Capital Management, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 1,224 shares of BDX stock, worth $291,483. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,224
Previous 1,241 1.37%
Holding current value
$291,483
Previous $307,000 6.84%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$225.07 - $246.17 $3,826 - $4,184
-17 Reduced 1.37%
1,224 $286,000
Q1 2024

May 14, 2024

SELL
$233.45 - $247.73 $67,000 - $71,098
-287 Reduced 18.78%
1,241 $307,000
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $4,180 - $4,810
-18 Reduced 1.16%
1,528 $372,000
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $162,626 - $180,930
-638 Reduced 29.21%
1,546 $399,000
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $91,303 - $101,617
383 Added 21.27%
2,184 $576,000
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $70,061 - $79,101
-305 Reduced 14.48%
1,801 $445,000
Q4 2022

Feb 14, 2023

SELL
$218.29 - $256.91 $75,964 - $89,404
-348 Reduced 14.18%
2,106 $535,000
Q3 2022

Oct 24, 2022

SELL
$51.03 - $264.23 $41,385 - $214,290
-811 Reduced 24.84%
2,454 $546,000
Q2 2022

Aug 08, 2022

SELL
$234.74 - $275.42 $23,708 - $27,817
-101 Reduced 3.0%
3,265 $804,000
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $85,517 - $94,938
351 Added 11.64%
3,366 $895,000
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $37,042 - $40,401
161 Added 5.64%
3,015 $758,000
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $11,636 - $12,823
50 Added 1.78%
2,854 $702,000
Q2 2021

Aug 12, 2021

SELL
$232.65 - $254.58 $48,158 - $52,698
-207 Reduced 6.87%
2,804 $682,000
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $68,698 - $76,036
296 Added 10.9%
3,011 $732,000
Q4 2020

Feb 11, 2021

BUY
$221.92 - $245.94 $37,504 - $41,563
169 Added 6.64%
2,715 $679,000
Q3 2020

Nov 10, 2020

BUY
$215.77 - $276.76 $7,767 - $9,963
36 Added 1.43%
2,546 $592,000
Q2 2020

Aug 10, 2020

SELL
$219.9 - $263.41 $53,875 - $64,535
-245 Reduced 8.89%
2,510 $601,000
Q1 2020

May 12, 2020

BUY
$195.69 - $279.01 $38,746 - $55,243
198 Added 7.74%
2,755 $680,000
Q4 2019

Jan 24, 2020

SELL
$236.45 - $266.82 $55,092 - $62,169
-233 Reduced 8.35%
2,557 $696,000
Q3 2019

Nov 05, 2019

SELL
$230.58 - $256.08 $304,596 - $338,281
-1,321 Reduced 32.13%
2,790 $706,000
Q2 2019

Jul 18, 2019

BUY
$217.4 - $246.08 $533,934 - $604,372
2,456 Added 148.4%
4,111 $1.04 Million
Q1 2019

Apr 18, 2019

BUY
$206.05 - $248.17 $8,242 - $9,926
40 Added 2.48%
1,655 $413,000
Q4 2018

Jan 25, 2019

SELL
$204.73 - $257.93 $17,606 - $22,181
-86 Reduced 5.06%
1,615 $364,000
Q3 2018

Oct 17, 2018

BUY
$233.07 - $256.0 $10,721 - $11,776
46 Added 2.78%
1,701 $446,000
Q2 2018

Jul 27, 2018

SELL
$208.1 - $233.85 $70,129 - $78,807
-337 Reduced 16.92%
1,655 $396,000
Q1 2018

Apr 06, 2018

SELL
$205.46 - $240.27 $352,158 - $411,822
-1,714 Reduced 46.25%
1,992 $432,000
Q4 2017

Jan 25, 2018

BUY
$189.0 - $222.64 $288,414 - $339,748
1,526 Added 70.0%
3,706 $793,000
Q3 2017

Oct 03, 2017

BUY
$186.89 - $198.9 $407,420 - $433,602
2,180
2,180 $427,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $67.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.